Bosserman L - Search Results

1

Reconstitution of T-cell function after CD6-depleted allogeneic bone marrow transplantation.

Soiffer RJ, Bosserman L, Murray C, Cochran K, Daley J, Ritz J. Soiffer RJ, et al. Among authors: bosserman l. Blood. 1990 May 15;75(10):2076-84. Blood. 1990. PMID: 1970938 Free article.

2

Total lymphoid irradiation to prevent graft rejection in recipients of HLA non-identical T cell-depleted allogeneic marrow.

Soiffer RJ, Mauch P, Tarbell NJ, Anderson KC, Freedman AS, Rabinowe SN, Takvorian T, Murrey CI, Coral F, Bosserman L, et al. Soiffer RJ, et al. Among authors: bosserman l. Bone Marrow Transplant. 1991 Jan;7(1):23-33. Bone Marrow Transplant. 1991. PMID: 2043874

3

Mechanism of graft failure in HLA-matched and HLA-mismatched bone marrow transplant recipients.

Bosserman LD, Murray C, Takvorian T, Anderson KC, Freedman AS, Fitzsimmons J, Coral F, Nadler LM, Schlossman SF, Ritz J. Bosserman LD, et al. Bone Marrow Transplant. 1989 May;4(3):239-45. Bone Marrow Transplant. 1989. PMID: 2659109

4

Successful treatment of disseminated Fusarium infection after autologous bone marrow transplantation for acute myeloid leukemia.

Robertson MJ, Socinski MA, Soiffer RJ, Finberg RW, Wilson C, Anderson KC, Bosserman L, Sang DN, Salkin IF, Ritz J. Robertson MJ, et al. Among authors: bosserman l. Bone Marrow Transplant. 1991 Aug;8(2):143-5. Bone Marrow Transplant. 1991. PMID: 1933056

5

Treatment of low-grade and intermediate-grade lymphoma with intensive combination chemotherapy results in long-term, disease-free survival.

Licht JD, Bosserman LD, Andersen JW, Yeap BY, Klatt MM, Martel JK, Anderson KC, Rosenthal DS, Pinkus G, Skarin AT, et al. Licht JD, et al. Among authors: bosserman ld. Cancer. 1990 Aug 15;66(4):632-9. doi: 10.1002/1097-0142(19900815)66:4<632::aid-cncr2820660405>3.0.co;2-b. Cancer. 1990. PMID: 1696844

6

A phase II study of gemcitabine and docetaxel therapy in patients with advanced urothelial carcinoma.

Gitlitz BJ, Baker C, Chapman Y, Allen HJ, Bosserman LD, Patel R, Sanchez JD, Shapiro RM, Figlin RA. Gitlitz BJ, et al. Cancer. 2003 Nov 1;98(9):1863-9. doi: 10.1002/cncr.11726. Cancer. 2003. PMID: 14584068 Free article. Clinical Trial.

7

Correlation of drug-induced apoptosis assay results with oncologist treatment decisions and patient response and survival.

Bosserman LD, Rajurkar SP, Rogers K, Davidson DC, Chernick M, Hallquist A, Malouf D, Presant CA. Bosserman LD, et al. Cancer. 2012 Oct 1;118(19):4877-83. doi: 10.1002/cncr.27444. Epub 2012 Feb 21. Cancer. 2012. PMID: 22354845 Free article. Clinical Trial.

8

Final 5-year results of Z-FAST trial: adjuvant zoledronic acid maintains bone mass in postmenopausal breast cancer patients receiving letrozole.

Brufsky AM, Harker WG, Beck JT, Bosserman L, Vogel C, Seidler C, Jin L, Warsi G, Argonza-Aviles E, Hohneker J, Ericson SG, Perez EA. Brufsky AM, et al. Among authors: bosserman l. Cancer. 2012 Mar 1;118(5):1192-201. doi: 10.1002/cncr.26313. Epub 2011 Oct 10. Cancer. 2012. PMID: 21987386 Free article. Clinical Trial.

9

Maintenance of clinical efficacy after dose reduction of ixabepilone plus capecitabine in patients with anthracycline- and taxane-resistant metastatic breast cancer: a retrospective analysis of pooled data from 2 phase III randomized clinical trials.

Valero V, Vrdoljak E, Xu B, Thomas E, Gómez H, Manikhas A, Medina C, Li RK, Ro J, Bosserman L, Vahdat L, Mukhopadhyay P, Opatt D, Sparano JA. Valero V, et al. Among authors: bosserman l. Clin Breast Cancer. 2012 Aug;12(4):240-6. doi: 10.1016/j.clbc.2012.03.013. Epub 2012 Jun 2. Clin Breast Cancer. 2012. PMID: 22658378 Clinical Trial.

10

TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer.

Yardley DA, Arrowsmith ER, Daniel BR, Eakle J, Brufsky A, Drosick DR, Kudrik F, Bosserman LD, Keaton MR, Goble SA, Bubis JA, Priego VM, Pendergrass K, Manalo Y, Bury M, Gravenor DS, Rodriguez GI, Inhorn RC, Young RR, Harwin WN, Silver C, Hainsworth JD, Burris HA 3rd. Yardley DA, et al. Breast Cancer Res Treat. 2017 Aug;164(3):649-658. doi: 10.1007/s10549-017-4285-6. Epub 2017 May 15. Breast Cancer Res Treat. 2017. PMID: 28508185 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68 results

Search Page